Weight of evidence: A review of concept and methods

Risk Analysis

Volumn 25, Issue 6, 2005, Pages 1545-1557

  Weed, Douglas L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Causal criteria; Methods; Quality criteria; Risk assessment; Systematic reviews; Weight of evidence

Indexed keywords

PUBLIC POLICY; QUALITY CONTROL; RISKS; TOXIC MATERIALS;

CAUSAL CRITERIA; METHODS; QUALITY CRITERIA; SYSTEMATIC REVIEWS; WEIGHT OF EVIDENCE;

RISK ASSESSMENT;

ALCOHOL; POLYCHLORINATED BIPHENYL; TOBACCO SMOKE;

CONCEPTUAL FRAMEWORK; PLANNING METHOD; RISK ASSESSMENT;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; CARCINOGENICITY; CAUSAL CRITERIA; DOSE RESPONSE; EPIDEMIOLOGY; EXHAUST GAS; HUMAN; MEDLINE; META ANALYSIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TOXICOLOGY; WEIGHT OF EVIDENCE;

EPIDEMIOLOGY; HUMANS; META-ANALYSIS; PUBLIC HEALTH; RISK ASSESSMENT; TOXICOLOGY;

EID: 31944435095     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2005.00699.x     Document Type: Review

References (116)

1. National Research Council. (1983). Risk Assessment in the Federal Government: Managing the Process. Washington, DC: National Academy Press.
2. Weed, D. L. (1997). Underdetermination and incommensurability in contemporary epidemiology. Kennedy Institute of Ethics Journal, 7, 107-127.
3. Weed, D. L. (1997). Methodologic guidelines for review papers (editorial). Journal of the National Cancer Institute, 89, 6-7.
4. Allen, J. S., Campbell, J. A., Cariello, N. F., Kutz, S. A., Thilagar, A., Xu, J., Ham, A. L., & Mitchell, A. D. (2003). Genetic toxicology of remifentanil, an opiate analgesic. Teratogenesis, Carcinogenesis and Mutagenesis, Suppl 1, 137-149.
5. Awad, A. G., Voruganti, L. N. (2004). Impact of atypical antipsychotics on quality of life in patients with schizophrenia. CNS Drugs, 18, 877-893.
6. Azadpour, M., & Lamas, G. A. (2004). AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction. Expert Review of Cardiovascular Therapy, 2, 891-902.
7. Berkahn, L., & Keating, A. (2004). Hematopoiesis in the elderly. Hematology, 9, 159-163.
8. Boriani, G., Biffi, M., Martignani, C., Camanini, C., Grigioni, F., Rapezzi, C., & Branzi, A. (2003). Cardioverter-defibrillators after MADIT-II: The balance between weight of evidence and treatment costs. European Journal of Heart Failure, 5, 419-425.
9. Brown, P. D., Buckner, J. C., Uhm, J. H., & Shaw, E. G. (2003). The neurocognitive effects of radiation in adult low-grade glioma patients. Neuro-oncology, 5, 161-167.
10. Calabrese, E. J., Baldwin, L. A., Kostecki, P. T., & Potter, T. L. (1997). A toxicologically based weight-of-evidence methodology for the relative ranking of chemicals of endocrine disruption potential. Regulatory Toxicology and Pharmacology, 26, 36-40.
11. Caslake, M. J., Packard, C. J. (2003). Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Current Opinion in Lipidology, 14, 347-352.
12. Cohen, S. M., Klaunig, J., Meek, M. E., Hill, R. N., Pastoor, T., Lehman-McKeeman, L., Bucher, J., Longfellow, D. G., Seed, J., Dellarco, V., Fenner-Crisp, P., & Patton, D. (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicological Sciences, 78, 181-186.
13. Cohen, S. M. (2004). Risk assessment in the genomic era. Toxicological Pathology, 32(Supplement 1), 3-8.
14. Cohen, S. M. (2001). Alternative models for carcinogenicity testing: Weight of evidence evaluations across models. Toxicological Pathology, 29 Suppl, 183-190.
15. Coo, H., & Aronson, K. J. (2004). A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology, 23, 1-12.
16. Cooper, R. L., & Kavlock, R. J. (1997). Endocrine disruptors and reproductive development: A weight-of-evidence overview. Journal of Endocrinology, 152, 159-166.
17. Cox, K., & Wilson, E. (2003). Follow-up for people with cancer: Nurse-led services and telephone interventions. Journal of Advances in Nursing, 43, 51-61.
18. Crane, J. L., & MacDonald, D. D. (2003). Applications of numerical sediment quality targets for assessing sediment quality conditions in a US Great Lakes area of concern. Environmental Management, 32(1), 128-140.
19. Crofton, K. M., Makris, S. L., Sette, W. F., Mendez, E., Raffaele, K. C. (2004). A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies Neurotoxicological Teratology, 26, 345-352.
20. De Rosemond, S. J., & Liber, K. (2004). Wastewater treatment polymers identified as the toxic component of a diamond mine effluent. Environment and Toxicological Chemistry, 23, 2234-2242.
21. Denham, M. C., & Whittaker, J. C. (2003). A Bayesian approach to disease gene location using allelic association. Biostatistics, 4, 399-409.
22. Donnelly, J. P., Bellm, L. A., Epstein, J. B., & Sonis, S. T., Symonds, R. P. (2003). Antimicrobial therapy to prevent or treat oral mucositis. Lancet Infectious Diseases, 3(7), 405-412.
23. Erratum in Lancet Infectious Diseases 2003 3(9), 598.
24. Doull, J., Rozman, K. K., & Lowe, M. C. (1996). Hazard evaluation in risk assessment: Whatever happened to sound scientific judgment and weight of evidence? Drug Metabolism Reviews, 28, 285-299.
25. Dulin, N. O., Fernandes, D. J., Dowell, M., Bellam, S., McConville, J., Lakser, O., Mitchell, R., Camoretti-Mercado, B., & Kogut, P., Solway, J. (2003). What evidence implicates airway smooth muscle in the cause of BHR? Clinical Reviews in Allergy and Immunology, 24, 73-84.
26. Edwards, A., Elwyn, G., Hood, K., & Rollnick, S. (2000). Judging the "weight of evidence" in systematic reviews: Introducing rigour into the equalitative overview stage by assessing signal and noise. J Evaluation of Clinical Practice, 6, 177-184.
27. Elder, J. A., & Chou, C. K. (2003). Auditory response to pulsed radiofrequency energy. Bioelectromagnetics Suppl 6, S162-S173.
28. Elder, J. A. (2003). Survival and cancer in laboratory mammals exposed to radiofrequency energy. Bioelectromagnetics, Suppl 6, S101-S106.
29. Evans, M. D., Dizdaroglu, M., & Cooke, M. S. (2004). Oxidative DNA damage and disease: Induction, repair and significance. Mutation Research, 567, 1-61.
30. Gamble, J. F. (1994). Asbestos and colon cancer: A weight of the evidence review. Environmental Health Perspectives, 102, 1038-1050.
31. Golden, R., Doull, J., Waddell, W., & Mandel, J. (2003). Potential human cancer risks from exposure to PCBs: A tale of two evaluations. Critical Reviews of Toxicology, 33, 543-580.
32. Graves, C. G., Matanoski, G. M., & Tardiff, R. G. (2001). Weight of evidence for an association between adverse reproductive and developmental effects and exposure to disinfection by-products: A critical review. Regulatory Toxicology and Pharmacology, 34, 103-124.
33. Greene, J. F., Hays, S., & Paustenbach, D. (2003). Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: A weight of evidence evaluation of the human and animal studies. Journal of Toxicology and Environmental Health B Critical Review, 6, 115-159.
34. Griffiths, H., & Molony, N. C. (2003). Does asbestos cause laryngeal cancer? Clinical Otolaryngology, 28(3), 177-182. Review.
35. Erratum in Clinical Otolaryngology 2004 29(2), 197.
36. Gutcher, I., Webb, P. R., & Anderson, N. G. (2003). The isoform-specific regulation of apoptosis by protein kinase C. Cellular and Molecular Life Sciences, 60, 1061-1070.
37. Hall, E. J., & Brenner, D. J. (2003). The weight of evidence does not support the suggestion that exposure to low doses of X rays increases longevity. Radiology, 229, 18-19.
38. Halton, T. L., & Hu, F. B. (2004). The effects of high protein diets on thermogenesis, satiety and weight loss: A critical review. Journal of American College of Nutrition, 23, 373-385.
39. Handy, R. D., Galloway, T. S., & Depledge, M. H. (2003). A proposal for the use of biomarkers for the assessment of chronic pollution and in regulatory toxicology. Ecotoxicology, 12, 331-343.
40. Hays, J. T., & Ebbert, J. O. (2003). Bupropion for the treatment of tobacco dependence: Guidelines for balancing risks and benefits. CNS Drugs, 17, 71-83.
41. Healy, C. E., Kier, L. D., Broeckaert, F., & Martens, M. A. (2003). A review of the genotoxicity of triallate. International Journal of Toxicology, 22, 233-251.
42. Holmes, C. C., & Heard, N. A. (2003). Generalized monotonic regression using random change points. Statistics in Medicine, 22, 623-638.
43. Hughes, K., Meek, M. E., Walker, M., & Beauchamp, R. (2003). 1,3-Butadiene: Exposure estimation, hazard characterization, and exposure-response analysis. Journal Toxicology and Environmental Health B Critical Review, 6, 55-83.
44. Hull, M. S., Cherry, D. S., & Bayaricks, T. C. (2004). Effect of cage design on growth of transplanted Asian clams: Implications for assessing bivalve responses in streams. Environmental Monitoring and Assessment, 96, 1-14.
45. Jinot, J., & Bayard, S. (1994). Respiratory health effects of passive smoking: EPA's weight-of-evidence analysis. Journal of Clinical Epidemiology, 47, 339-49; discussion 351-353.
46. King, R. S., & Richardson, C. J. (2003). Integrating bioassessment and ecological risk assessment: An approach to developing numerical water-quality criteria. Environmental Management, 31, 795-809.
47. Kirkland, D., & Marzin, D. (2003). An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of Henna. Mutation Research, 537(2), 183-199.
48. Kirman, C. R., Sweeney, L. M., Teta, M. J., Sielken, R. L., Valdez-Flores, C., Albertini, R. J., & Gargas, M. L. (2004). Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: Cancer potency estimates for ethylene oxide. Risk Analysis, 24(5), 1165-1183.
49. Krzywinski, J., Wilkerson, R. C., & Besansky, N. J. (2001). Toward understanding Anophelinae (Diptera, Culicidae) phylogeny: Insights from nuclear single-copy genes and the weight of evidence. Systemic Biology, 50(4), 540-556.
50. Lynch, A., Harvey, J., Aylott, M., Nicholas, E., Burman, M., Siddiqui, A., Walker, S., & Rees, R. (2003). Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity. Mutagenesis, 18(4), 345-353.
51. MacDonald, J. S. (2004). Human carcinogenic risk evaluation, part IV: Assessment of human risk of cancer from chemical exposure using a global weight-of-evidence approach. Toxicological Sciences, 82(1), 3-8.
52. Mathie, R. T. (2003). The research evidence base for homeopathy: A fresh assessment of the literature. Homeopathy, 92(2), 84-91.
53. Matsuda, H. (2004). The importance of type II error and falsifiability. International Journal of Occupational Medicine and Environmental Health, 17(1), 137-145.
54. Mauthe, R. J., Gibson, D. P., Bunch, R. T., & Custer, L. (2001). Syrian Hamster Embryo Assay Working Group. Response to "Alternative models for carcinogenicity testing: Weight of evidence across models" Sam Cohen, Toxicologic Pathology, 29(suppl.), 183-190.
55. Toxicological Pathology, 30(2), 292-293.
56. Maxim, L. D., & McConnell, E. E. (2001). Interspecies comparisons of the toxicity of asbestos and synthetic vitreous fibers: A weight-of-the-evidence approach. Regulatory Toxicology and Pharmacology, 33(3), 319-342.
57. McMasters, K. M., & Swetter, S. M. (2003). Current management of melanoma: Benefits of surgical staging and adjuvant therapy. Journal of Surgical Oncology, 82(3), 209-216.
58. Melnick, R. L., Kohn, M. C., & Huff, J. (1997). Weight of evidence versus weight of speculation to evaluate the alpha2u-globulin hypothesis. Environmental Health Perspectives, 105(9), 904-906.
59. Meltz, M. L. (2003). Radiofrequency exposure and mammalian cell toxicity, genotoxicity, and transformation. Bioelectromagnetics, Suppl 6, S196-S213.
60. Menzie, C., Henning, M. H., Cura, J., Finkelstein, K., Gentile, J., Maughan, J., Mitchell, D., Petron, S., Potocki, B., Svirsky, S., & Tyler, P. (1996). Special report of the Massachusetts weight-of-evidence workgroup: A weight-of-evidence approach for evaluating ecological risks. Human Ecological Risk Assessment, 2(2), 277-304.
61. Mohr, L. C., Rodgers, J. K., & Silvestri, G. A. (2003). Glutathione S-transferase M1 polymorphism and the risk of lung cancer. Anticancer Research, 23(3A), 2111-2124.
62. Narula, G., & Bawa, K. S. (2003). Neurocysticercosis - New millennium, ancient disease and unending debate. Indian Journal of Pediatrics, 70(4), 337-342.
63. Nohynek, G. J., Fautz, R., Benech-Kieffer, F., & Toutain, H. (2004). Toxicity and human health risk of hair dyes. Food and Chemical Toxicology, 42(4), 517-543.
64. O'Donovan, M. C., Williams, N. M., & Owen, M. J. (2003). Recent advances in the genetics of schizophrenia. Human and Molecular Genetics, 12 Spec No 2, R125-33.
65. Owen, M. J., Williams, N. M., & O'Donovan, M. C. (2004). The molecular genetics of schizophrenia: New findings promise new insights. Molecular Psychiatry, 9(1), 14-27.
66. Pepelko, B., Seckar, J., Harp, P. R., Kim, J. H., Gray, D., & Anderson, E. L. (2004). Worker exposure standard for phosphine gas. Risk Analysis, 24(5), 1201-1213.
67. Pinner, G., & Bouman, W. P. (2003). Attitudes of patients with mild dementia and their carers towards disclosure of the diagnosis. International Psychogeriatrics. 15(3), 279-288.
68. Pohl, H. R., Roney, N., Wilbur, S., Hansen, H., & De Rosa, C. T. (2003). Six interaction profiles for simple mixtures. Chemosphere, 53(2), 183-197.
69. Pothos, E. M., & Ward, R. (2000). Symmetry, repetition, and figural goodness: An investigation of the weight of evidence theory. Cognition, 75(3), B65-78.
70. Proctor, D. M., Otani, J. M., Finley, B. L., Paustenbach, D. J., Bland, J. A., Speizer, N., & Sargent, E. V. (2002). Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review. Journal of Toxicological and Environmental Health A, 65(10), 701-746. Review.
71. Quigley, D. G., Arnold, J., Eldridge, P. R., Cameron, H., McIvor, K., Miles, J. B., & Varma, T. R. (2003). Long-term outcome of spinal cord stimulation and hardware complications. Stereotactical and Functional Neurosurgery, 81(1-4), 50-56.
72. Rao, V., Hinz, M. E., Roberts, B. A., & Fine, D. (2004). Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526. Vaccine, 22(20), 2667-2673.
73. Recer, G. M. (2004), A review of the effects of impermeable bedding encasements on dust-mite allergen exposure and bronchial hyper-responsiveness in dust-mite-sensitized patients. Clinical and Experimental Allergy, 34(2), 268-275. Review.
74. Richardson, D. P., Affertsholt, T., Asp, N. G., Bruce, A., Grossklaus, R., Hewlett, J., Pannemans, D., Ross, R., Verhagen, H., & Viechtbauer, V. (2003). PASSCLAIM-Synthesis and review of existing processes. European Journal of Nutrition, 42 Suppl 1, I96-I111.
75. Rusnock, A. A. (1995). The weight of evidence and the burden of authority: Case histories, medical statistics and small-pox inoculation. Clio Medica, 29, 289-315.
76. Sachs, G. S. (2003). Decision tree for the treatment of bipolar disorder. Journal of Clinical Psychiatry, 64 Suppl 8, 35-40.
77. Salas, A., Lareu, M. V., & Carracedo, A. (2001). Heteroplasmy in mtDNA and the weight of evidence in forensic mtDNA analysis: A case report. International Journal of Legal Medicine, 114(3), 186-190.
78. Sanders, M. E., Tompkins, T., Heimbach, J. T., & Kolida, S. (2005). Weight of evidence needed to substantiate a health effect for probiotics and prebiotics: Regulatory considerations in Canada, E.U., and U.S. European Journal of Nutrition, 44(5), 303-310.
79. Schantz, S. L., Widholm, J. J., & Rice, D. C. (2003). Effects of PCB exposure on neuropsychological function in children. Environmental Health Perspectives, 111(3), 357-576.
80. Schultz, T. W., & Cronin, M. T. (2003). Essential and desirable characteristics of ecotoxicity quantitative structure-activity relationships. Environmental and Toxicological Chemistry, 22(3), 599-607.
81. Siddall, R. (2002). Managers & medicine. Weight of evidence. Health Service Journal, 112(5791), 34-36.
82. Sloter, E., Nath, J., Eskenazi, B., & Wyrobek, A. J. (2004). Effects of male age on the frequencies of germinal and heritable chromosomal abnormalities in humans and rodents. Fertilility and Sterility, 81(4), 925-943.
83. Snodin, D. J. (2004). Regulatory immunotoxicology: Does the published evidence support mandatory nonclinical immune function screening in drug development? Regulatory Toxicology and Pharmacology, 40(3), 336-355.
84. Spicer, J., Smith, P., Maclennan, K., Hoskin, P., Hancock, B., Linch, D., & Pettengell, R. (2004). Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma. British Journal of Cancer, 90(6), 1151-1155.
85. Springer, A. M., Estes, J. A., van Vliet, G. B., Williams, T. M., Doak, D. F., Danner, E. M., Forney, K. A., & Pfister, B. (2003). Sequential megafaunal collapse in the North Pacific Ocean: An ongoing legacy of industrial whaling? Proceedings of the National Academy of Sciences USA, 100(21), 12223-12228.
86. Staudte, R. G., & Zhang, J. (1997). Weighing the evidence for hypotheses with small samples of right-censored exponential data. Lifetime Data Analysis, 3(4), 383-398.
87. Stelljes, M. E., & Wood, R. R. (2004). Development of an occupational exposure limit for n-propylbromide using bench-mark dose methods. Regulatory Toxicology and Pharmacology, 40(2), 136-150.
88. Stoller, J. K. (2003). Key current clinical issues in alpha-1 antitrypsin deficiency. Respiratory Care, 48(12), 1216-1221; discussion 1221-1224.
89. Tariot, P. N., & Federoff, H. J. (2003). Current treatment for Alzheimer disease and future prospects. Alzheimer Disease and Associated Disorders, 17 Suppl 4, S105-S113.
90. Thomas, K., Aalbers, M., Bannon, G. A., Bartels, M., Dearman, R. J., Esdaile, D. J., Fu, T. J., Glatt, C. M., Hadfield, N., Hatzos, C., Hefle, S. L., Heylings, J. R., Goodman, R. E., Henry, B., Herouet, C., Holsapple, M., Ladics, G. S., Landry, T. D., MacIntosh, S. C., Rice, E. A., Privalle, L. S., Steiner, H. Y., Teshima, R., Van Ree, R., Woolhiser, M., & Zawodny, J. (2004). A multi-laboratory evaluation of a common in vitro pepsin digestion assay protocol used in assessing the safety of novel proteins. Regulatory Toxicology and Pharmacology, 39(2), 87-98.
91. Thompson, B., & Lowe, S. (2004). Assessment of macrobenthos response to sediment contamination in the San Francisco Estuary, California, USA. Environmental and Toxicological Chemistry, 23(9), 2178-2187.
92. Upton, A. C. (2003). National Council on Radiation Protection and Measurements Scientific Committee 1-6. The state of the art in the 1990's: NCRP Report No. 136 on the scientific bases for linearity in the dose-response relationship for ionizing radiation. Health Physics, 85(1), 15-22.
93. Varela-Calvino, R., & Peakman, M. (2003). Enteroviruses and type 1 diabetes. Diabetes Metabolism Research and Reviews, 19(6), 431-441.
94. Walker, V. R. (1996). Risk characterization and the weight of evidence: Adapting gatekeeping concepts from the courts. Risk Analysis, 16(6), 793-799.
95. Walsh, E. P., & Cecchin, F. (2004). Recent advances in pacemaker and implantable defibrillator therapy for young patients. Current Opinions in Cardiology. 19(2), 91-96.
96. Webbe, F. M., & Ochs, S. R. (2003). Recency and frequency of soccer heading interact to decrease neurocognitive performance. Applied Neuropsychology, 10(1), 31-41.
97. Willhite, C. C. (2001). Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: Di(2 ethylhexyl)phthalate (DEHP). Toxicology, 160(1-3), 219-226.
98. Wogan, G. N., Hecht, S. S., Felton, J. S., Conney, A. H., & Loeb, L. A.,(2004) Environmental and chemical carcinogenesis. Seminars in Cancer Biology 14(6), 473-486.
99. U.S. Environmental Protection Agency. (1996). Proposed Guidelines for Carcinogen Risk Assessment. Washington, DC: Office of Research and Development, U.S. Environmental Protection Agency.
100. U.S. Environmental Protection Agency. (2005) Guidelines for Carcinogen Risk Assessment. EPA/630/P-03/001F. Washington, DC: U.S. Environmental Protection Agency.
101. U.S. Environmental Protection Agency. (2004). An Examination of EPA Risk Assessment Principles and Practices. EPA/100/B-04/001. Washington, DC: Office of the Science Advisor, U.S. Environmental Protection Agency.
102. Hill, A. B. (1965). The environment and disease: Association or causation? Journal of the Royal Society of Medicine, 58, 295-300.
103. Gerner, E. W. (2005). Changing winds in the war on cancer. Cancer Biology and Therapy, 4(2), 252-254.
104. Weed, D. L. (1998). Beyond black box epidemiology. American Journal of Public Health, 88, 12-14.
105. Slavin, R. E. (1995). Best evidence synthesis: An intelligent alternative to meta-analysis. Journal of Clinical Epidemiology, 48, 9-18.
106. Breslow, R. A., Ross, S. A., & Weed, D. L. (1998). Quality of reviews in epidemiology. American Journal of Public Health, 88, 475-477.
107. Klimisch, H. J., Andreae, M., & Tillmann, U. (1997). A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regulatory Toxicology and Pharmacology, 25(1), 1-5.
108. Surgeon General's Advisory Committee on Smoking and Health. (1964). Smoking and Health: Rockville, MD: U.S. Public Health Service (DHEW publication no. (PHS) 1103).
109. Weed, D. L. & Gorelic, L. S. (1996). The practice of causal inference in cancer epidemiology. Cancer Epidemiology, Biomarkers and Prevention, 5, 303-311.
110. Weed, D. L. (1997). On the use of causal criteria. International Journal of Epidemiology, 26, 1137-1141.
111. Holman, C. D., Arnold-Reed, D. E., de Klerk, K., McComb, C., & English, D. R. (2001). A psychometric experiment in causal inference to estimate evidential weights used by epidemiologists. Epidemiology. 12(2), 246-255.
112. Weed, D. L. (2000). Interpreting epidemiologic evidence: How meta-analysis and causal inference methods are related. International Journal of Epidemiology, 29, 387-90.
113. Weed, D. L., & Hursting, S. D. (1998). Biologic plausibility in causal inference: Current method and practice. American Journal of Epidemiology, 147, 415-425.
114. Mumtaz, M. M., & Durkin, P. R. (1992). A weight of evidence approach for assessing interactions in chemical mixtures. Toxicology and Industrial Health, 8, 377-406.
115. Di Marco, P. N., Priestly, B. G., & Buckett, K. J. (1998). Carcinogen risk assessment. Can we harmonise? Toxicological Letters 102-103, 241-246.
116. Weed, D. L. (2002). Environmental epidemiology: Basics and proof of cause-effect. Toxicology, 181-182, 399-403.